Perhaps Kanecia should wake up and smell the coffee they are brewing:

https://rethinkingclinicaltrials.org/news/gra...hd-md-mph/

“test known and novel interventions across domains”
“This broad set of clinical conditions and varied underlying causes underscore the need for testing a broad portfolio of therapeutic agents.”